Tri Locum Partners’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-51,810
Closed -$2.08M 68
2022
Q2
$2.08M Buy
+51,810
New +$3.78M 0.85% 28
2022
Q1
Sell
-13,558
Closed -$3.38M 56
2021
Q4
$3.38M Buy
13,558
+394
+3% +$87.5K 1.33% 20
2021
Q3
$2.58M Sell
13,164
-330
-2% -$65.8K 1.03% 23
2021
Q2
$2.7M Sell
13,494
-1,506
-10% -$306K 0.88% 23
2021
Q1
$3.04M Hold
15,000
0.75% 25
2020
Q4
$3.2M Buy
+15,000
New +$3.12M 1.16% 24

Other funds holding SNCE

Tri Locum Partners's SNCE Position: Q3 2022 in Review

Tri Locum Partners sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2022, closing a stake of 51,810 shares — an estimated $2.08M sold.

Tri Locum Partners first reported a position in SNCE in Q4 2020 and held it in 6 quarters. The position peaked at $3.38M in Q4 2021. 68 funds tracked by Wall St. Rank hold SNCE as of Q3 2022.

  • Tri Locum Partners reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Tri Locum Partners sold 51,810 Science 37 Holdings, Inc. Common Stock shares in Q3 2022, an estimated $2.08M.
  • Tri Locum Partners first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Tri Locum Partners's Science 37 Holdings, Inc. Common Stock position peaked at $3.38M in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2022.

Based on Tri Locum Partners's 13F filing for Q3 2022, filed 14 Nov 2022.